AKR1B10 and hepatocellular carcinoma: The authors of that study also investigated whether hepatoma-like cells derived from hiPSCs of HCC patients can be transformed into normal hepatocyte cells upon treatment with acyclic retinoid and AKR1B10 inhibitor (tolestat).